17-beta-hydroxysteroid dehydrogenase deficiency differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Tag: Reverted
No edit summary
 
(5 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{17-beta-hydroxysteroid dehydrogenase deficiency}}
{{17-beta-hydroxysteroid dehydrogenase deficiency}}
17 beta hydroxysteroid dehydrogenase deficiency should be differentiated from other diseases that cause [[ambiguous genitalia]].
{{CMG}}, {{AE}} {{Abdulkerim}}
==Overview==
17 beta hydroxysteroid dehydrogenase deficiency should be differentiated from other diseases that cause [[ambiguous genitalia]]
==Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases==
*17 beta hydroxysteroid dehydrogenase deficiency should be differentiated from other diseases that cause [[ambiguous genitalia]].<ref name="pmid30508571">{{cite journal| author=Folsom LJ, Hjaige M, Liu J, Eugster EA, Auchus RJ| title=Germ cell neoplasia in situ complicating 17β-hydroxysteroid dehydrogenase type 3 deficiency. | journal=Mol Cell Endocrinol | year= 2019 | volume= 489 | issue=  | pages= 3-8 | pmid=30508571 | doi=10.1016/j.mce.2018.11.014 | pmc=6511466 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30508571  }} </ref><ref name="pmid7810070">{{cite journal| author=White PC| title=Genetic diseases of steroid metabolism. | journal=Vitam Horm | year= 1994 | volume= 49 | issue=  | pages= 131-95 | pmid=7810070 | doi=10.1016/s0083-6729(08)61147-4 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7810070  }} </ref>
{| class="wikitable"
{| class="wikitable"
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease name
! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease name
Line 79: Line 83:
* [[Virilization]] in a 46,XX individual with normal female internal anatomy
* [[Virilization]] in a 46,XX individual with normal female internal anatomy
* Causes include maternal [[luteoma]] or theca-[[lutein]] [[cysts]], and [[placental]] [[aromatase]] enzyme deficiency
* Causes include maternal [[luteoma]] or theca-[[lutein]] [[cysts]], and [[placental]] [[aromatase]] enzyme deficiency
|}<ref name="pmiddoi.org/10.1210/edrv.21.5.0411">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=doi.org/10.1210/edrv.21.5.0411 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10  }} </ref>
|}
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Latest revision as of 17:59, 2 July 2022

17-beta-hydroxysteroid dehydrogenase deficiency Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Molecular Genetic Studies

Genotyping

X Ray

CT

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

17-beta-hydroxysteroid dehydrogenase deficiency differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of 17-beta-hydroxysteroid dehydrogenase deficiency differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on 17-beta-hydroxysteroid dehydrogenase deficiency differential diagnosis

CDC on 17-beta-hydroxysteroid dehydrogenase deficiency differential diagnosis

17-beta-hydroxysteroid dehydrogenase deficiency differential diagnosis in the news

Blogs on 17-beta-hydroxysteroid dehydrogenase deficiency differential diagnosis

Directions to Hospitals Treating 17-beta-hydroxysteroid dehydrogenase deficiency

Risk calculators and risk factors for 17-beta-hydroxysteroid dehydrogenase deficiency differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Abdulkerim Yassin, M.B.B.S[2]

Overview

17 beta hydroxysteroid dehydrogenase deficiency should be differentiated from other diseases that cause ambiguous genitalia

Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases

  • 17 beta hydroxysteroid dehydrogenase deficiency should be differentiated from other diseases that cause ambiguous genitalia.[1][2]
Disease name Steroid status Important clinical findings
Increased Decreased
Classic type of 21-hydroxylase deficiency
11-β hydroxylase deficiency
17-α hydroxylase deficiency
3 beta-hydroxysteroid dehydrogenase deficiency
Gestational hyperandrogenism

References

  1. Folsom LJ, Hjaige M, Liu J, Eugster EA, Auchus RJ (2019). "Germ cell neoplasia in situ complicating 17β-hydroxysteroid dehydrogenase type 3 deficiency". Mol Cell Endocrinol. 489: 3–8. doi:10.1016/j.mce.2018.11.014. PMC 6511466 Check |pmc= value (help). PMID 30508571.
  2. White PC (1994). "Genetic diseases of steroid metabolism". Vitam Horm. 49: 131–95. doi:10.1016/s0083-6729(08)61147-4. PMID 7810070.

Template:WH Template:WS